ISO/TC 212
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 85347 | ISO/PWI TS 18702 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for exosomes and other extracellular vesicles in venous whole blood — DNA, RNA and proteins | Izstrādē |
| 85346 | ISO/PWI TS 18701 | Molecular in vitro diagnostic examinations — Specificationsfor pre-examination processes for human specimens — Isolated microbiome DNA | Izstrādē |
| 85074 | ISO/NP TS 17849 | Guidance on the validation and verification of quantitative and qualitative methods | Izstrādē |
| 84816 | ISO/TS 16766:2024 | Manufacturers’ considerations for in vitro diagnostic medical devices in a public health emergency | Standarts spēkā |
| 83899 | ISO/WD TS 8219 | Sequencing and clinical application to infectious diseases | Izstrādē |
| 83565 | ISO 21474-3:2024 | In vitro diagnostic medical devices — Multiplex molecular testing for nucleic acids — Part 3: Interpretation and reports | Standarts spēkā |
| 81712 | ISO/TS 5798:2022 | In vitro diagnostic test systems — Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods | Atcelts |
| 81506 | ISO 5649:2024 | Medical laboratories — Concepts and specifications for the design, development, implementation and use of laboratory-developed tests | Standarts spēkā |
| 79379 | ISO 16256:2021 | Clinical laboratory testing and in vitro diagnostic test systems — Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against yeast fungi involved in infectious diseases | Standarts spēkā |
| 79378 | ISO 17593:2022 | Clinical laboratory testing and in vitro medical devices — Requirements for in vitro monitoring systems for self-testing of oral anticoagulant therapy | Standarts spēkā |
Displaying 31-40 of 142 results.